Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06183476 · ClinicalTrials.gov registry record · NA
Circadian Amplification in Diabetic Retinopathy
A NA study of Diabetic Retinopathy, sponsored by University of Illinois at Chicago.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
- 1
- Study location
NCT06183476 is a NA study of Diabetic Retinopathy that has completed, run by University of Illinois at Chicago. The registered enrollment target is 8 participants, below the 1,676-participant average among 57 other Diabetic Retinopathy trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06183476, a NA study of Diabetic Retinopathy, has completed, sponsored by University of Illinois at Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will test the effects of a 6-week comprehensive circadian optimization intervention Amplify-RHYTHM in patients with diabetic retinopathy. The outcomes of interest are objective and subjective sleep parameters, evening salivary cortisol and melatonin levels, and glucose parameters from continuous glucose monitoring
Conditions Studied
Interventions
- BEHAVIORAL Amplify-RHYTHM
Study Locations (1)
Illinois
- University of Illinois at Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2024-03-20 |
| Est. Completion | 2025-01-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06183476
The ClinicalTrials.gov registry entry for NCT06183476 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,676-participant average among 57 other Diabetic Retinopathy trials with a reported enrollment target (100% lower). The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Diabetic Retinopathy appearing as the primary indexed condition, and to 1 intervention - of which Amplify-RHYTHM is the first listed.
NCT06183476 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT06183476 about?
NCT06183476 is a clinical study titled "Circadian Amplification in Diabetic Retinopathy". This study will test the effects of a 6-week comprehensive circadian optimization intervention Amplify-RHYTHM in patients with diabetic retinopathy. The outcomes of interest are objective and subjective sleep parameters, evening salivary cortisol and melatonin levels, and glucose parameters from con...
What is the current status of trial NCT06183476?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2024-03-20. Estimated completion is 2025-01-10.
What conditions does trial NCT06183476 study?
This clinical trial studies the following conditions: Diabetic Retinopathy.
What interventions are being tested in trial NCT06183476?
The interventions under investigation include: Amplify-RHYTHM (BEHAVIORAL).
Who is sponsoring clinical trial NCT06183476?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06183476 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Retinopathy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Village-Integrated Eye Worker Trial II
RECRUITING · NA
-
Video-based Patient Education Intervention for Diabetic Eye Screening in Latinx Communities
RECRUITING · NA
-
Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease
RECRUITING · NA
-
Clinical Applications of Advanced Ophthalmic Imaging
RECRUITING · NA
-
Implementation of Teleophthalmology in Urban Health Systems Study
ACTIVE NOT RECRUITING · NA
-
Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT)
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.